Discovery of novel selective hypotensive vasopressin peptides that exhibit little or no functional interactions with known oxytocin/vasopressin receptors-Reference-Cited by-同舟云学术

Discovery of novel selective hypotensive vasopressin peptides that exhibit little or no functional interactions with known oxytocin/vasopressin receptors

Published:1998-10 Issue:4 Volume:125 Page:803-811
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Chan W Y,Wo N C,Stoev S,Cheng L L,Manning M

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/sj.bjp.0702114/fullpdf

Reference46 articles.

1. Vascular smooth muscle and neurohypophyseal hormones;Altura;Fed. Proc.,1977

2. Hemodynamic and coagulation responses to 1-deamino[8-D-arginine]vasopressin in patients with congenital nephrogenic diabetes insipidus;Bichet;New Eng. J. Med.,1988

3. Influence of vasopressin and angiotensin on baroreflexes in the dog;Cowley;Cir. Res.,1984

4. Uterine and placental prostaglandins and their modulation of oxytocin sensitivity and contractility in the parturient uterus;Chan;Biol. Reprod.,1983

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aquaporins, Vasopressin, and Aging: Current Perspectives;Endocrinology;2015-03-01

2. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents☆;Advances in Vasopressin and Oxytocin — From Genes to Behaviour to Disease;2008

3. Impact of the Merrifield solid phase method on the design and synthesis of selective agonists and antagonists of oxytocin and vasopressin: A historical perspective;Biopolymers;2007-07-03

4. The Role of the Merrifield Solid Phase Method in the Discovery and Exploration of a New Class of Selective Vasopressin Hypotensive Agonists;International Journal of Peptide Research and Therapeutics;2007-03-10

5. Design and synthesis of potent, highly selective vasopressin hypotensive agonists;Journal of Peptide Science;2006